Art

J-GLOBAL ID：201802219450329667   Reference number：18A1053044

Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands

新規改変Toll様受容体2リガンドで被覆した細菌模倣腫瘍細胞に基づくワクチンの開発

Author (6)： Akazawa Takashi (Department of Tumor Immunology, Research Center, Osaka International Cancer Institute, Osaka, Japan) ,  Ohashi Toshimitsu (Department of Tumor Immunology, Research Center, Osaka International Cancer Institute, Osaka, Japan) ,  Ohashi Toshimitsu (Department of Otolaryngology, Gifu University Graduate School of Medicine, Gifu City, Japan) ,  Wijewardana Viskam (Department of Advanced Pathobiology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka, Japan) ,  Sugiura Kikuya (Department of Advanced Pathobiology, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka, Japan) ,  Inoue Norimitsu (Department of Tumor Immunology, Research Center, Osaka International Cancer Institute, Osaka, Japan)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 109  Issue： 5  Page： 1319-1329  Publication year： 2018 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *peptide ,...
Semi thesaurus term： *TLR2

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1053044&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： adjuvant ,  bacterial lipopeptide ,  drug design ,  toll-like receptor ligand ,  tumor vaccine

JST classification (1)： Experimental treatment for tumors  (GE02040Y)

Terms in the title (8)： 改変 ,  Toll様受容体2 ,  リガンド ,  細菌 ,  模倣 ,  腫瘍細胞 ,  ワクチン ,  開発